Drilldown: Medicines - Pharmacopedia

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Opioid

or Stimulant

or [[:Category:Intranasal_antihistamines|Intranasal antihistamine]]

Use the filters below to narrow your results.

Codeine (2)

None (54) · (multiple, generic dominant) (1) · Alfenta (1) · Astelin, Astepro (intranasal); Optivar (ophthalmic); with fluticasone as Dymista (1) · Benzedrex (1) · Darvon (1) · Demerol (1) · Dilaudid (1) · Dolophine (1) · Duragesic (1) · Heroin (1) · Krokodil (1) · Nubain (1) · Nucynta (1) · O-DSMT (1) · Opana (1) · Stablon (1) · Stadol (1) · Suboxone (1) · Sufenta (1) · Talwin (1) · Ultiva (1) · Vicodin (1)

Monoamine releasing agent (8) · Potent mu-opioid receptor agonist (6) · Dopamine/norepinephrine reuptake inhibitor (5) · Mu-opioid receptor agonist (4) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2)

Other values:

None (74) · Mild to moderate pain; cough suppression (low-dose). (1) · '"`UNIQ--vote-000013B3-QINU`"', '"`UNIQ--vote-000013B4-QINU`"', '"`UNIQ--vote-000013B5-QINU`"' (1)

None (74) · Adult: 15–60 mg every 4 hours as needed. (1) · Intranasal 0.1% or 0.15%: 1-2 sprays/nostril BID; ophthalmic 0.05%: 1 drop in each eye BID (1)

None (74) · 0.1%, 0.15% intranasal spray; 0.05% ophthalmic solution; combination Dymista (azelastine 0.137 mg + fluticasone 50 mcg/spray) (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (74) · 2 sprays/nostril BID (1) · 360 mg/day (1)

None (74) · Intranasal (1) · PO (only formulation marketed in the US). (1) · topical ophthalmic (1)

None (74) · 15 minutes (1) · 30–60 min (PO) (1)

None (74) · 12 hours (1) · 4–6 hours (1)

None (74) · 2.5–3 hours (1) · ~22 hours; longer 54 hours (desmethylazelastine, active metabolite)'"`UNIQ--ref-000013B6-QINU`"' (1)

None (74) · Intranasal ~40% systemic; ophthalmic minimal'"`UNIQ--ref-000013B7-QINU`"' (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1)

None (74) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Limited data; second-line to intranasal corticosteroids or PO loratadine/cetirizine.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1)

None (74) · OTC (Astepro 0.15%) and [[USLegal:Prescription only|Rx-only]] (other intranasal, ophthalmic, Dymista) in US (1) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)

Showing below up to 76 results in range #1 to #76.

2

3

4

7

7-Hydroxymitragynine

A

B

C

Cyclazodone

D

E

F

Fentanyl

H

I

Isopropylphenidate

K

Kratom

L

Levorphanol

M

N

O

P

R

S

Sufentanil

T

U

U-47700

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"